Enrique Alvarez
University of Colorado, Denver
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Enrique Alvarez as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:51 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07757568 · Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)University of Colorado, Denver · active not recruiting · Multiple Sclerosis (MS) Relapsing Remitting · principal investigator
- Ph4NCT06529406 · Prospective Evaluation of Sequencing From antiCD-20 Therapies to OzanimodUniversity of Colorado, Denver · recruiting · Relapsing Multiple Sclerosis · principal investigator
- Ph3NCT02980042 · Safety of Switching From Rituximab to Ocrelizumab in MS PatientsUniversity of Colorado, Denver · completed · Multiple Sclerosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:51 UTC. The ranking covers the 200 most relevant of 114 PubMed records, and a shared surname and initials can bring in a namesake. All 114 on PubMed
- 267 citationsRCR 9.8
- Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.N Engl J Med · 2018230 citationsRCR 9.7
- Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.N Engl J Med · 2022184 citationsRCR 14.9
- A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.Int J Neuropsychopharmacol · 2012176 citationsRCR 7.0
- Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.J Clin Psychiatry · 2007169 citationsRCR 5.3
- Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression.Int J Neuropsychopharmacol · 2012164 citationsRCR 5.5
- 154 citationsRCR 4.3
- Dorsal subthalamotomy for Parkinson's disease.Mov Disord · 2001139 citationsRCR 4.1
- Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.Clin Infect Dis · 2001136 citationsRCR 4.1
- A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.Arch Gen Psychiatry · 1999124 citationsRCR 4.4